Ecallantide bulk supplier for pharma manufacturers

Ecallantide Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10 mg/mL

Reference Brands: Kalbitor(USA/EU)

Category: Immune Disorder

Ecallantide is a recombinant plasma kallikrein inhibitor used to treat acute hereditary angioedema (HAE) attacks. It works by blocking kallikrein activity, reducing the production of bradykinin, and thereby preventing or decreasing swelling. Ecallantide is available in Injection and strengths such as 10 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ecallantide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Ecallantide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Ecallantide is used for the treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years and older. It works by inhibiting plasma kallikrein, which reduces the production of bradykinin and alleviates swelling.

It is made from a recombinant protein that acts as a potent and selective plasma kallikrein inhibitor.

The trade name is Kalbitor.

Kalbitor is manufactured by Dyax Corp, a subsidiary of Shire Pharmaceuticals.

The generic name is Ecallantide.

The brand name is Kalbitor.

It is manufactured in approved biologics production facilities in the United States for commercial distribution.

Yes, Ecallantide is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Ecallantide is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Ritlecitinib

Strength:
50 mg

Form: Capsules

Reference Brands: Litfulo (USA/EU)

View Details
Sarilumab

Strength:
150 mg/1.14 mL, 200 mg/1.14 mL

Form: injection (prefilled syringe)

Reference Brands: Kevzara (USA/EU)

View Details
Canakinumab

Strength:
150 mg/mL

Form: Injection

Reference Brands: Ilaris (USA/EU)

View Details
Iptacopan

Strength:
200mg

Form: Capsules

Reference Brands: Fabhalta (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.